Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley dealEli Lilly will acquire AtaiBeckley for up to $3.8 billion. This deal aims to develop psychedelic treatments for depression and other mental...
16 Jul, 2026, 05.22 PM IST
Fatty liver new treatment found: Study discovers a medicine that reverses severe fatty liver by just repairing the gutA new experimental drug shows promise for severe fatty liver disease. This compound targets the gut, not the liver directly. It repairs a d...
15 Jul, 2026, 03.20 PM IST
Sun Pharma gets SAHPRA approval for generic semaglutide injection in South Africa for type 2 diabetesSouth Africa's regulator approved Sun Pharma's generic semaglutide injection for diabetes. This approval allows marketing to supplement die...
15 Jul, 2026, 11.26 AM IST
92% of people will be affected by cancer at least once in their lifetime, says WHOCancer affects nearly everyone globally, with one in five developing the disease. The world recorded over twenty million new cases and ten ...
10 Jul, 2026, 12.44 PM IST
Bryan Johnson disease: The autoimmune condition that can increase cancer risk over time and often goes undetected. Check causes, symptoms, treatment and other detailsBryan Johnson autoimmune disease: Anti-aging personality Bryan Johnson's recent revelation of autoimmune disease has ignited public interes...
06 Jul, 2026, 02.21 PM IST
‘Nobody should be left alone with a strong drug and a printout’: After Ketto, Kunal Kapoor’s next healthcare betAfter helping families finance critical treatments through Ketto, Kunal Kapoor is now focused on preventing those medical emergencies befor...
06 Jul, 2026, 10.44 AM IST
Shantha Biologics to make injectable drug cartridges for Novo NordiskShantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...
02 Jul, 2026, 03.15 PM IST
'Cheaper than a gym, but still not selling': Nithin Kamath on why Indians aren't embracing popular weight-loss drugsDespite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges wi...
30 Jun, 2026, 07.27 PM IST
Why do people snore? Causes, symptoms, risks and how to stop snoringSnoring, often dismissed as a mere annoyance, can signal underlying health issues like sleep apnea. The sound arises from obstructed breath...
30 Jun, 2026, 10.45 AM IST
Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for those who are not diabetic or clinically obese...'Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...
27 Jun, 2026, 09.43 PM IST
India’s GLP-1 boom loses steam as price war, weak retention hit generic weight-loss drug salesInitial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...
26 Jun, 2026, 03.22 PM IST
Pfizer CFO Dave Denton to leave company in AugustPfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure r...
19 Jun, 2026, 12.13 AM IST
Jeremy Clarkson cancer: The ‘aggressive’ diagnosis he caught early and the symptoms men shouldn’t ignoreJeremy Clarkson has revealed his diagnosis with an aggressive form of prostate cancer, detected last summer and treated with surgery. Prost...
17 Jun, 2026, 09.38 PM IST
The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
15 Jun, 2026, 11.08 AM IST
India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
12 Jun, 2026, 11.48 PM IST
UK approves Novo weight-loss pill to edge open European marketBritain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...
12 Jun, 2026, 08.36 AM IST
US stocks: Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss marketLilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...
08 Jun, 2026, 10.14 PM IST